Literature DB >> 9013451

Dominantly transmitted glomerulocystic kidney disease: a distinct genetic entity.

C K Sharp1, S M Bergman, J M Stockwin, M L Robbin, C Galliani, L M Guay-Woodford.   

Abstract

Glomerulocystic kidney disease (GCKD) is a relatively rare condition with both a sporadic and familial occurrence. Pathologically, GCKD is characterized by cystic dilatation of Bowman's space and the initial proximal convoluted tubule. As a heritable disorder, GCKD has primarily been recognized in infants with a family history of classic, autosomal dominant polycystic kidney disease (ADPKD). Dominantly transmitted GCKD associated with either hypoplastic or normal-sized kidneys has also been reported in older children and adults. A large, three-generation African-American family with familial GCKD is characterized. Of the 20 individuals available for study, seven affected individuals were identified by renal sonogram or renal histopathology. GCKD in this family segregates as an autosomal dominant trait as evidenced by its apparent transmission from a father to his sons. A set of directed linkage strategies indicates that the distinctive GCKD phenotype in this family results from a dominantly acting mutation that disrupts a genetic locus distinct from the ADPKD loci, PKD1 and PKD2, as well the human homologue of mouse jcpk mutation, a newly described murine GCKD. These analyses are the first known genetic studies conducted in a family with heritable GCKD and post-infantile age of onset.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9013451     DOI: 10.1681/ASN.V8177

Source DB:  PubMed          Journal:  J Am Soc Nephrol        ISSN: 1046-6673            Impact factor:   10.121


  8 in total

1.  Loss of primary cilia upregulates renal hypertrophic signaling and promotes cystogenesis.

Authors:  P Darwin Bell; Wayne Fitzgibbon; Kelli Sas; Antine E Stenbit; May Amria; Amber Houston; Ryan Reichert; Sandra Gilley; Gene P Siegal; John Bissler; Mehmet Bilgen; Peter Cheng-te Chou; Lisa Guay-Woodford; Brad Yoder; Courtney J Haycraft; Brian Siroky
Journal:  J Am Soc Nephrol       Date:  2011-04-14       Impact factor: 10.121

2.  Glomerulocystic kidney disease in mice with a targeted inactivation of Wwtr1.

Authors:  Zakir Hossain; Safiah Mohamed Ali; Hui Ling Ko; Jianliang Xu; Chee Peng Ng; Ke Guo; Zeng Qi; Sathivel Ponniah; Wanjin Hong; Walter Hunziker
Journal:  Proc Natl Acad Sci U S A       Date:  2007-01-24       Impact factor: 11.205

Review 3.  Uromodulin: old friend with new roles in health and disease.

Authors:  Franca M Iorember; V Matti Vehaskari
Journal:  Pediatr Nephrol       Date:  2013-07-24       Impact factor: 3.714

4.  Mutations in the hepatocyte nuclear factor-1beta gene are associated with familial hypoplastic glomerulocystic kidney disease.

Authors:  C Bingham; M P Bulman; S Ellard; L I Allen; G W Lipkin; W G Hoff; A S Woolf; G Rizzoni; G Novelli; A J Nicholls; A T Hattersley
Journal:  Am J Hum Genet       Date:  2000-11-20       Impact factor: 11.025

5.  Glomerulocystic kidney disease in hypomelanosis of Ito.

Authors:  Gianluca Vergine; Francesca Mencarelli; Francesca Diomedi-Camassei; Gianluca Caridi; May El Hachem; Gian Marco Ghiggeri; Francesco Emma
Journal:  Pediatr Nephrol       Date:  2008-04-05       Impact factor: 3.714

Review 6.  Cystic kidney disease: the role of Wnt signaling.

Authors:  Madeline A Lancaster; Joseph G Gleeson
Journal:  Trends Mol Med       Date:  2010-06-22       Impact factor: 11.951

Review 7.  Role of transcription factor hepatocyte nuclear factor-1β in polycystic kidney disease.

Authors:  Annie Shao; Siu Chiu Chan; Peter Igarashi
Journal:  Cell Signal       Date:  2020-02-14       Impact factor: 4.315

Review 8.  Glomerulocystic kidney disease.

Authors:  John J Bissler; Brian J Siroky; Hong Yin
Journal:  Pediatr Nephrol       Date:  2010-01-21       Impact factor: 3.714

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.